Research programme: melanocortin 4 receptor agonists - ChemBridge Research Laboratories
Alternative Names: MC4 receptor agonists - CRLLatest Information Update: 16 Jul 2016
At a glance
- Originator ChemBridge Research Laboratories
- Class
- Mechanism of Action Melanocortin type 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Metabolic disorders; Obesity
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Metabolic-disorders in USA
- 16 Jul 2016 No recent reports of development identified for research development in Obesity in USA
- 12 Jul 2007 Early research in Metabolic disorders in USA (unspecified route)